Tag Archives: Cancer

AstraZeneca: Exciting ROpel Phase III trial results demonstrate the potential for Lynparza with abiraterone to become a new 1st-line option for patients with metastatic castration-resistant prostate cancer

(PRESS RELEASE) CAMBRIDGE, 24-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced positive high-level results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone demonstrated a … Read the full press release

TUM, DKTK, University Medical Center Göttingen researchers looked into how pancreatic and extrahepatic bile duct cancers develop

Why identical mutations cause different types of cancer Cancer development is influenced by tissue type (PRESS RELEASE) MUNICH, 20-Jul-2021 — /EuropaWire/ — Technical University of Munich (TUM), one of Europe’s leading universities, has announced that its Professor for Translational Cancer … Read the full press release

Cure for prostate cancer on the horizon

(PRESS RELEASE) FREIBURG, Germany, 1-Jul-2021 — /EuropaWire/ — Prostate cancer is the second most common cancer. According to the American Cancer Association, 1 in every 8 men will be diagnosed with it in their lifetime. In 2018 around 1.2 million … Read the full press release

Sanofi launches more impactful Corporate Social Responsibility (CSR) strategy

Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global nonprofit unit to provide 40 of the world’s poorest countries access to 30 essential medicines (PRESS RELEASE) PARIS, 7-Apr-2021 — … Read the full press release

Latest research and future treatment in heart rhythm disorders to be presented at EHRA 2021

(PRESS RELEASE) Sophia Antipolis Cedex, France, 29-Mar-2021 — /EuropaWire/ — European Society of Cardiology (ESC) announces that its online scientific congress EHRA 2021 will be held 23 to 25 April online. Highlights of the congress are the latest practice-changing research … Read the full press release

Aviva announces new partnership agreement with UK cancer charity Macmillan Cancer Support

(PRESS RELEASE) LONDON, 15-Feb-2021 — /EuropaWire/ — British multinational insurance company Aviva to help its protection customers living with cancer get access to the emotional, clinical and financial support they need through a new partnership agreement with leading UK cancer … Read the full press release

Vodafone now UK’s top contributor to The World Community Grid helping academics and scientists fight against COVID-19

Plans in place to become a top 10 global contributor (PRESS RELEASE) BERKSHIRE, 11-Sep-2020 — /EuropaWire/ — British multinational telecommunications company Vodafone (LON: VOD) has announced it has become UK’s top daily contributor of computer processing power to the World … Read the full press release

Roche unveils automated digital pathology algorithm to aid non-small cell lung cancer diagnosis

uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumour cell staining positivity Roche advances personalised healthcare with development of image analysis algorithms using artificial intelligence Faster, more accurate … Read the full press release

NWO: Spinoza Prize / Stevin Prize, the highest distinction in Dutch Science, awarded to six outstanding researchers

(PRESS RELEASE) THE HAGUE, 19-Jun-2020 — /EuropaWire/ — The Dutch Research Council (NWO) has announced that six researchers will receive the highest awards in science in the Netherlands. The Spinoza Prize, emphasised on the scientific work and fundamental questions, will … Read the full press release

Liver cancer: Roche’s Tecentriq in combination with Avastin approved by US FDA

Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen approved for the treatment of unresectable or metastatic hepatocellular carcinoma Tecentriq combination improved overall survival and progression-free survival compared to the previous standard of care Application approved … Read the full press release

University of Zurich researchers announce novel immunotherapy against leukaemia

The new immunotherapy will be tested in humans as soon as possible (PRESS RELEASE) ZURICH, 8-May-2020 — /EuropaWire/ — University of Zurich researchers have announced a study that is showing how hematopoietic stem cells from a healthy donor can help … Read the full press release

First non-melanoma skin cancer patients treated with the Rhenium-SCT® in Germany

The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau (PRESS RELEASE) HANAU, Germany, 4-Oct-2019 — /EuropaWire/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), … Read the full press release

OncoBeta® chosen as a 2019 Red Herring North America Top 100 Winner

New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients. (PRESS RELEASE) Pasadena, CA, U.S.A., 5-Jul-2019 — /EuropaWire/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin … Read the full press release

Rhenium-SCT® (SCT= Skin Cancer Therapy) now being offered in Hanau, Germany

The interregional professional association for nuclear medicine in Hanau is the first treatment center in Germany offering Rhenium-SCT® for the treatment of non-melanoma skin cancer (PRESS RELEASE) GARCHING N. MUNICH, Germany, 13-May-2019 — /EuropaWire/ — OncoBeta® GmbH, a commercial stage … Read the full press release

First Non-Melanocytic Skin Cancer Patients treated with Rhenium-SCT® in South Africa

University of Pretoria Prof. Mike Sathekge is First in South Africa to Treat Non-Melanocytic Skin Cancer Patients with Rhenium-SCT® Garching n. Munich, Germany, 26-Nov-2018 — /EuropaWire/ — OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope … Read the full press release

Exeter paper wins Cancer Research Paper of the Year award

EXETER, 05-Oct-2018 — /EuropaWire/ — An Exeter paper has won Research Paper of the Year under the cancer category in the Royal College for General Practitioners (RCGP) Research Awards. The paper, published in 2017, found that having a high blood platelet … Read the full press release

Novartis: the global Phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor BYL719 has met the primary endpoint

SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on or following treatment with an aromatase inhibitor with or without a CDK4/6 inhibitor[1] Approximately 40% of HR+ advanced breast cancer … Read the full press release

AstraZeneca and Merck & Co., Inc. announce positive results from the randomised, double-blinded, placebo-controlled, Phase III SOLO-1 trial of Lynparza (olaparib) tablets

Lynparza met primary endpoint of progression-free survival in women with BRCA-mutated advanced ovarian cancer and showed a safety profile consistent with previous trials AstraZeneca and MSD’s Lynparza is the only PARP inhibitor to demonstrate significant activity in the 1st-line maintenance … Read the full press release

KTH and Karolinska Institutet: AI can contribute to increased understanding of how prostate cancer develops

Researchers at KTH and Karolinska Institutet have concluded that AI can contribute to increased understanding of how prostate cancer develops, and even improve clinical diagnosis and treatment of the disease. STOCKHOLM, 28-Jun-2018 — /EuropaWire/ — Every cancer tumor is unique, … Read the full press release

Dr Emmanouela Gbandi appointed as the Solving Kids’ Cancer Senior Trials Coordinator for Neuroblastoma at the University of Birmingham’s Cancer Research UK Clinical Trials Unit (CRCTU)

University of Birmingham researchers are leading the way with a ground-breaking role to enable more children with the rare cancer neuroblastoma to access potentially life-saving clinical trials more quickly. BIRMINGHAM, 12-Jun-2018 — /EuropaWire/ — In the first dedicated position focusing on … Read the full press release

University of Dundee Professor Bob Steele awarded a CBE in HM The Queen’s Birthday Honours list for his work on the treatment of colorectal cancer

DUNDEE, Scotland, 11-Jun-2018 — /EuropaWire/ — Professor Bob Steele, of the University of Dundee, has been awarded a CBE in HM The Queen’s Birthday Honours list for his work on the prevention, early detection and treatment of colorectal cancer. Professor Steele … Read the full press release

Royal Philips and Singapore Institute of Advanced Medicine Holdings open Advanced Medicine Imaging (AMI) center at Biopolis research hub in Singapore

First phase of Singapore’s Advanced Medicine Imaging Center provides accurate and timely diagnosis of cancer, plus an education center for medical training and scientific research collaborations New treatment innovations, including radioisotope and proton beam therapies, will be made progressively available … Read the full press release

Paul Scherrer Institute PSI inaugurates new treatment unit for proton therapy against cancer

With millimetre precision, certain tumours can be irradiated at the Paul Scherrer Institute PSI using protons – that is, positively charged elementary particles. PSI is the one place in Switzerland where this especially protective and precise option for radiation therapy … Read the full press release

University of Leeds and University of Birmingham scientists discovered the role of one of the crucial proteins responsible for allowing HPV to infect cells

LEEDS, 03-May-2018 — /EuropaWire/ — New drugs in the early stages of development by pharmaceutical companies could have an extra benefit – the ability to cancel out HPV virus, which can cause cervical cancer and skin conditions. Scientists at the … Read the full press release

Pioneering study will pool cancer patient information from hundreds of hospitals to directly compare surgery quality in more than 100 countries across four continents

COVENTRY, 02-May-2018 — /EuropaWire/ — Improved care for patients undergoing cancer surgery is the focus of a pioneering worldwide study. Doctors say the initiative will enable them to gauge surgery quality across the globe and highlight ways to improve patient … Read the full press release

Animal rescue hero loses his heroic battle with cancer

MANAMA, Bahrain, 21-Apr-2018 — /EuropaWire/ — In a statement from his children they said: “It is with great sorrow that we announce that our father, Tony Waters AKA “The Dogfather” died today, 20th of April 2018, after a long battle … Read the full press release

KTH researchers produced microparticles with encapsulated cells that can be used as implants to fight cancer, diabetes or heart disease

STOCKHOLM, 18-Apr-2018 — /EuropaWire/ — One way that cancer may be fought in the future is with micro-sized capsules containing living cells engineered to secrete toxins that attack cancer cells. Although the science of cell micro-encapsulation has yet to overcome certain … Read the full press release

STFC and EPSRC launch funding call with Cancer Research UK to drive forward earlier detection of cancer

SWINDON, 12-Apr-2018 — /EuropaWire/ — STFC and EPSRC have launched a joint funding call with Cancer Research UK that aims to drive forward earlier detection of cancer. The new funding called ‘Early Detection Innovation Sandpit and Award’ is available to researchers, … Read the full press release

Research evaluated the effectiveness of three-month course chemotherapy for colorectal cancer versus the standard six-month treatment regimen

SOUTHAMPTON, 02-Apr-2018 — /EuropaWire/ — Many patients receiving chemotherapy following surgery for bowel cancer may only need three months treatment rather than the six months currently given, new research published in Lancet Oncology has shown. An international clinical trial, funded by … Read the full press release

Roche: Phase III IMpower131 study met its co-primary endpoint of progression-free survival of people with a type of advanced squamous lung cancer

BASEL, 20-Mar-2018 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane [albumin-bound … Read the full press release